Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Can animal models help us select specific compounds for cancer prevention trials?

Hawk ET, Umar A, Lubet RA, Kopelovich L, Viner JL.

Recent Results Cancer Res. 2005;166:71-87. Review.

PMID:
15648184
[PubMed - indexed for MEDLINE]
2.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
[PubMed - indexed for MEDLINE]
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
4.

The mighty mouse: genetically engineered mouse models in cancer drug development.

Sharpless NE, Depinho RA.

Nat Rev Drug Discov. 2006 Sep;5(9):741-54. Epub 2006 Aug 18. Review.

PMID:
16915232
[PubMed - indexed for MEDLINE]
5.

Mouse models in oncogenesis and cancer therapy.

Céspedes MV, Casanova I, Parreño M, Mangues R.

Clin Transl Oncol. 2006 May;8(5):318-29. Review.

PMID:
16760006
[PubMed - indexed for MEDLINE]
6.

Relevance of animal carcinogenesis findings to human cancer predictions and prevention.

Maronpot RR, Flake G, Huff J.

Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:40-8. Review.

PMID:
15209402
[PubMed - indexed for MEDLINE]
Free Article
7.

Do we make optimal use of the potential of cancer prevention?

Greenwald P, Dunn BK.

Recent Results Cancer Res. 2009;181:3-17. Review.

PMID:
19213552
[PubMed - indexed for MEDLINE]
8.

Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.

Hansen K, Khanna C.

Eur J Cancer. 2004 Apr;40(6):858-80. Review.

PMID:
15120042
[PubMed - indexed for MEDLINE]
9.

Inhibition of tumorigenesis in animals.

Wattenberg LW.

IARC Sci Publ. 1996;(139):151-8. Review.

PMID:
8923027
[PubMed - indexed for MEDLINE]
10.

The promise of genetically engineered mice for cancer prevention studies.

Green JE, Hudson T.

Nat Rev Cancer. 2005 Mar;5(3):184-98. Review.

PMID:
15738982
[PubMed - indexed for MEDLINE]
11.

The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.

Klein RD.

Mutat Res. 2005 Aug 25;576(1-2):111-9. Review.

PMID:
15885713
[PubMed - indexed for MEDLINE]
12.

Satraplatin: BMS 182751, BMY 45594, JM 216.

[No authors listed]

Drugs R D. 2007;8(2):125-32. Review.

PMID:
17324011
[PubMed - indexed for MEDLINE]
13.

The use and refinement of rodent models in anti-cancer drug discovery: a review.

Curwen JO, Wedge SR.

Altern Lab Anim. 2009 Apr;37(2):173-80. Review.

PMID:
19453212
[PubMed - indexed for MEDLINE]
14.

The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.

Hursting SD, Nunez NP, Patel AC, Perkins SN, Lubet RA, Barrett JC.

Mutat Res. 2005 Aug 25;576(1-2):80-92. Review.

PMID:
15990122
[PubMed - indexed for MEDLINE]
15.

Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.

Korff S, Harvey BH.

Psychiatr Clin North Am. 2006 Jun;29(2):371-90. Review.

PMID:
16650714
[PubMed - indexed for MEDLINE]
16.

Harnessing genetically engineered mouse models for preclinical testing.

Robles AI, Varticovski L.

Chem Biol Interact. 2008 Jan 30;171(2):159-64. Epub 2007 Feb 8. Review.

PMID:
17362899
[PubMed - indexed for MEDLINE]
18.

Probing p53 biological functions through the use of genetically engineered mouse models.

Attardi LD, Donehower LA.

Mutat Res. 2005 Aug 25;576(1-2):4-21. Review.

PMID:
16038709
[PubMed - indexed for MEDLINE]
19.

From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies.

Ottewell PD, Coleman RE, Holen I.

Breast Cancer Res Treat. 2006 Mar;96(2):101-13. Review.

PMID:
16319986
[PubMed - indexed for MEDLINE]
20.

Developing new agents for the treatment of childhood cancer.

Kurmasheva R, Morton C, Houghton PJ.

Curr Opin Investig Drugs. 2005 Dec;6(12):1215-27. Review.

PMID:
16372407
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk